Compare DNLI & SHOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DNLI | SHOO |
|---|---|---|
| Founded | 2013 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Shoe Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.2B |
| IPO Year | 2017 | 1996 |
| Metric | DNLI | SHOO |
|---|---|---|
| Price | $23.27 | $41.44 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 7 |
| Target Price | $34.33 | ★ $42.14 |
| AVG Volume (30 Days) | ★ 1.2M | 844.1K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 2.27% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.38 |
| Revenue | N/A | ★ $2,534,109,000.00 |
| Revenue This Year | N/A | $12.39 |
| Revenue Next Year | $408.85 | $5.90 |
| P/E Ratio | ★ N/A | $31.29 |
| Revenue Growth | N/A | ★ 11.00 |
| 52 Week Low | $12.58 | $28.91 |
| 52 Week High | $27.30 | $49.70 |
| Indicator | DNLI | SHOO |
|---|---|---|
| Relative Strength Index (RSI) | 41.67 | 32.03 |
| Support Level | $22.32 | $41.99 |
| Resistance Level | $23.62 | $44.62 |
| Average True Range (ATR) | 0.76 | 0.98 |
| MACD | -0.18 | -0.66 |
| Stochastic Oscillator | 8.33 | 5.79 |
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.
Steven Madden Ltd and its subsidiaries design, source, and market branded and private label footwear, accessories, and apparel. Its offerings include contemporary styles and core products, known for design creativity, trend-right offerings, high quality, and accessible price points. It operates through four segments: Wholesale Footwear, which generates maximum revenue and sells footwear globally; Wholesale Accessories/Apparel, which sells handbags and apparel through wholesale channels; Direct-to-Consumer, which sells footwear, handbags, apparel, and accessories through stores, outlets, e-commerce, and concessions; and Licensing, which licenses Steve Madden, Betsey Johnson, and Kurt Geiger trademarks, with the Company generating the majority of its revenue from the USA.